Veteran investor closes €725m biotech fund – seeks clinical-stage firms

16 Nov 2026
10:28
Sofinnova Partners has secured the final close of its life sciences growth fund at €725m.
One of Europe’s oldest VC firms, Sofinnova Partners has exited over 90 firms from its portfolio.
Here's what you need to know.
One of Europe’s oldest VC firms, Sofinnova Partners has exited over 90 firms from its portfolio.
Here's what you need to know.
French VC giant Sofinnova Partners has secured the final close of its latest Crossover fund at €725m.
Exceeding its original target, the firm claims the sizeable raise reflects the growing confidence in backing late-stage life sciences companies.